These comparative transcriptomic analyses allowed us to identify altered gene expression associated with TH17 subsets and their differentiation in subjects with MS and to identify associations of the expression of STAT3 in DN cells and IL10 in TH17 cells that are dependent on MS disease activity. This evidence concerns the gene STAT3 and myeloid sarcoma.